Funding News Edition: May 20, 2020 See more articles in this edition
NIAID is participating in a notice of special interest (NOSI) that encourages currently funded grantees to seek administrative supplements for new research focused on maternal mortality. Through the Notice of Special Interest: Administrative Supplements for NIH Grants To Add or Expand Research Focused on Maternal Mortality, investigators can address scientific priorities that will lay a foundation for the initiative Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE).
NIAID is especially interested in research projects focused on infection and immunity. Areas of interest include immune system dysregulation and autoimmunity during pregnancy and the postpartum period leading to poor pregnancy and maternal health outcomes. Refer to the NOSI for additional areas of research interest.
Keep in mind, the NOSI supports only research projects that are within the scope of an ongoing grant.
To apply, use Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp, Clinical Trial Optional). You must list “NOT-OD-20-104” in the Agency Routing Identifier field (box 4B) of the SF 424 R&R form. Be aware that NIH will reissue the funding opportunity announcement on May 25, 2020, as part of the transition to FORMS-F.
Your budget request cannot exceed $150,000 in direct costs. The project period is limited to one year. Additionally, your ongoing grant cannot be in the first or last year of its project period.
As with other administrative supplement applications, NIH staff will review your application rather than a peer review panel. Make sure your application demonstrates how the additional funding will advance science or medicine beyond what the current funding level could.
The deadline to apply is June 22, 2020.
Contact Dr. Juliane Caviston, NIAID’s scientific/research contact for the NOSI, if you have any questions.